Janssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU)...
Read moreUS-based drug maker Pfizer has confirmed that it has contacted AstraZeneca seeking to renew discussions over a possible £60bn takeover....
Read moreUS-based Alexion Pharmaceuticals has started a single, multinational, placebo-controlled trial designed to assess the safety and efficacy of eculizumab (Soliris)...
Read moreThe National Institute for Health and Care Excellence (NICE) in the UK has issued its final health technology appraisal recommending...
Read moreEli Lilly has obtained US Food and Drug Administration approval for its Cyramza (ramucirumab) as a single-agent treatment for patients...
Read moreUS-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose)...
Read morePleasanton, CA, USA, 21 February 2014 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a licensing agreement with Sysmex...
Read moreCopenhagen, Denmark, February 21, 2014 - Today announced that it has entered an exclusive license agreement with a subsidiary of...
Read moreA Phase IIa clinical study will test the efficacy, safety and tolerability profile Ferrer, a privately-held Spanish pharmaceutical company, today announces...
Read moreRoche announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation assessment at single-base resolution. This system...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.